Le Lézard
Classified in: Health
Subject: SVY

North America Patient Monitoring Device Market Report 2018: Market Reached USD 1,881.8 Million in 2013 and is Expected to Garner USD 3,329.9 Million by the End of 2024


DUBLIN, Dec. 11, 2018 /PRNewswire/ --

The "North America Patient (Human) Monitoring Device Market Outlook 2024" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The North America Patient Monitoring Devices market reached USD 1,881.8 Million in 2013 by registering a CAGR of 5.6% across the globe. Moreover, the market is expected to garner USD 3,329.9 Million by the end of 2024.

The North America demand for Patient Monitoring Devices is increasing due to massive growth of healthcare industry across the globe. Further, increasing awareness about growing incidences of cardiovascular diseases, respiratory diseases, renal disorders, different types of cancer, is also resulting in an increased demand for patient monitoring devices in the North America region.

United States is slated to account for a share of 84.1% by 2024 in the Patient Monitoring Devices market. The growth in the region can be attributed to growing incidence rates of diseases that require surgical intervention and constant or frequent monitoring, such as Cardiac Arrest, Arrhythmia, Cardiomyopathy, Coronary artery disease, heart failure, asthma, bronchitis, cystic fibrosis, chronic obstructive pulmonary disease, lung cancer, kidney transplants, kidney failures, other cancers and all surgical procedures performed under anesthesia.

Increasing technological innovations in Patient Monitoring Devices is also expected to impel the growth of Patient Monitoring Devices market in the North America. U.S. is the prominent market driving the growth in the region.

Additionally, U.S. Patient Monitoring Devices market reached USD 1,561.9 Million in 2013 and is expected to reach USD 2,800.5 Million by the end of 2024, expanding at a CAGR of 5.8% over the forecast period i.e. 2018-2024. U.S. Patient Monitoring Devices market is expected to achieve Y-o-Y growth rate of 6.1% in 2024 as compared to previous year.

The U.S. market is further segmented on the basis of product type into vital sign monitoring, infusion pumps, cardiac monitoring, respiratory monitoring devices, hematological monitoring devices, anesthesia systems monitoring devices, renal function monitoring devices, telemetry devices, multi-parameter monitors and other monitoring devices. In this segment vital sign monitoring devices hold the highest market share in 2013 and is expected to hold the same position with 30% share in the year 2024.

The U.S. market is also divided on the basis of Type into wireless and wired patient monitoring device within which wireless devices are expected to grow with the highest CAGR of 6.2% over the forecast period and is expected to capture a market value of USD 1,705.3 Million in the year 2024.

The U.S. market is also divided on the basis of End-User into hospitals, clinics, Research Institutions, Ambulatory Surgical Centers (ASCs) (comprising of independent endoscopy centers, day surgery centers, GI Labs), Independent ER Centers, Independent Long Term Acute Care and Nursing Centers.

Canada market is expected to expand at a CAGR of 5.0% during the forecast period i.e. 2018-2024. The market is projected to reach to a valuation of USD 529.5 Million by the end of 2024 from USD 319.9 Million in 2013. It is also expected to mark a growth rate of 5.3% in 2024.

Some of the major players in this market are Smith's Medical, Medtronic, GE Healthcare and Abbott.

Key Topics Covered:
 
1. Research Methodology

2. Market Definitions, Assumptions & Abbreviations

3. Market Taxonomy

4. Setting Up the Distribution Channel and Value Chain Analysis

5. Market Entry, Winning Strategies and Strategies to capture the clients

6. List of Potential Hospitals Ambulatory Surgical Centers

7. Process to Procure Patient (Human) Monitoring System

8. North America Patient (Human) Monitoring Devices Market - Executive Summary

9. Patient (Human) Monitoring Devices Product Overview

10. Recent Changes and Development in Patient (Human) Monitoring Devices Market by Geography

11. Regional Average Pricing Analysis, 2017

12. Patient Density Analysis

13. Supply Chain Analysis

14. Porter's Five Force Model Analysis

15. Patient (Human) Monitoring Devices Market - Risk Analysis

16. Market Dynamics & Its Impact Analysis

17. North America Patient (Human) Monitoring Devices Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2013-2024

18. Business Opportunities in the Patient(Human) Monitoring Devices Market, By Country

19. Competitive Landscape

20. Guide to the Industry by Region & Analyst's Recommendations

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/research/j2dcc3/north_america?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 16:19
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....

at 16:10
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...

at 16:10
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 shares of common stock (or pre-funded...

at 15:55
Valley Mountain Regional Center ("VMRC") experienced a data security incident that involved personal and / or protected health information belonging to certain current and former patients and has provided notice of this incident to impacted...

at 15:44
Late yesterday the United States District Court for the Northern California ruled that CVS acted intentionally under the "deliberate indifference" standard when it implemented a drug program that discriminates against people living with HIV....

at 15:33
Alameda Health System needs help identifying a patient who arrived at the Wilma Chan Highland Hospital Campus on March 15, 2024, without identification....



News published on and distributed by: